4-(Aminomethyl)benzoic acid is a kind of procoagulant drugs, mainly by inhibiting fibrinogen activator, so that fibrinogen can not be activated to fibrinolytic enzyme. Clinically, it is mainly used for bleeding caused by primary fibrinolysis, including acute and chronic, local or systemic hyperfibrinolytic bleeding.
Manufacturing
